RNA Sequencing Services Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: RNA Sequencing Services Market covers analysis by Type (Non Coding RNA Sequencing, Direct RNA Sequencing); Product (Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long ncRNA (lncRNA)); End Use (Academic and Government Institutes and Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00023193
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET OVERVIEW



RNA Sequencing is a procedure that uses next-generation sequencing (NGS) to divulge the presence also with the quantity of RNA in a biological sample at a given moment, analyzing the continuously changing cellular transcriptome. The RNA-Seq promotes the capability to look at other gene spliced transcripts, gene fusion, mutations/SNPs, post-transcriptional alterations, and changes in gene expression over time, or differences in gene expression in various groups or treatments.

MARKET SCOPE



The

"Global RNA Sequencing Services Market Analysis to 2031"

is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the RNA sequencing services market with detailed market segmentation by type, product, end use, and geography. The report provides key statistics on the market status of the leading RNA sequencing services market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  •  Based on type, the global RNA sequencing services market is segmented into non-coding rna sequencing, direct rna sequencing.
  •  On the basis of product, the market is segmented into ribosomal rna (rrna), transfer rna (trna), long ncrna (lncrna).
  •  On the basis of end use, the market is segmented into academic and government institutes and research centers, hospitals and clinics, pharmaceutical and biotechnology companies, other end users.

MARKET DYNAMICS


Drivers



  •   Rise in the demand for RNA sequencing over traditional technologies.
  •   Advancements in RNA sequencing workflow.

Restraints



  •   The initial capital investment and limited approaches are the major restraining factor for this market.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The RNA sequencing services market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the RNA sequencing services market in these regions.

IMPACT OF COVID-19 ON RNA SEQUENCING SERVICES MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the RNA sequencing services market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from RNA sequencing services market are anticipated to lucrative growth opportunities in the future with the rising demand for RNA sequencing services in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the RNA sequencing services market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Thermo Fisher
  •  BGI
  •  Illumina
  •  Active Motif
  •  CD Genomics
  •  Exiqon
  •  Novogene
  •  GENEWIZ
  •  LC Sciences
  •  Diagenode

The Insight Partner's dediRNA sequencing servicesed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

RNA Sequencing Services Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Non Coding RNA Sequencing
  • Direct RNA Sequencing
By Product
  • Ribosomal RNA
  • Transfer RNA
  • Long ncRNA
By End Use
  • Academic and Government Institutes and Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Other End Users
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher
  • BGI
  • Illumina
  • Active Motif
  • CD Genomics
  • Exiqon
  • Novogene
  • GENEWIZ
  • LC Sciences
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. Thermo Fisher
    2. BGI
    3. Illumina
    4. Active Motif
    5. CD Genomics
    6. Exiqon
    7. Novogene
    8. GENEWIZ
    9. LC Sciences
    10. Diagenode
    11. Arraystar
    12. BaseClear
    13. Phalanx Biotech
    14. CeGaT GmbH
    15. Genomax
    16. Qiagen

    Buy Now